OBP-301
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OBP-301, covering 2019-04-16 to 2019-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate Efficacy, Immunological Response of Intratumoral/Intralesional Oncolytic Virus (OBP-301) in Metastatic Melanoma [Phase 2]